| ID | Sequence | Length | GC content |
|---|---|---|---|
| GUGCGAUCAGAUCGAUCUAAGAUGGCGACUGUCGAACCGGUGAGUAUUG… | 2627 nt | 0.3708 | |
| GUGCGAUCAGAUCGAUCUAAGAUGGCGACUGUCGAACCGGAAACCACCC… | 2520 nt | 0.3508 | |
| GUGCGAUCAGAUCGAUCUAAGAUGGCGACUGUCGAACCGGGUGCUGUGA… | 2709 nt | 0.3577 | |
| GUGCGAUCAGAUCGAUCUAAGAUGGCGACUGUCGAACCGGAAACCACCC… | 2427 nt | 0.3449 |
The protein encoded by this gene is a component of the eukaryotic translation initiation factor 4F complex, which recognizes the 7-methylguanosine cap structure at the 5' end of messenger RNAs. The encoded protein aids in translation initiation by recruiting ribosomes to the 5'-cap structure. Association of this protein with the 4F complex is the rate-limiting step in translation initiation. This gene acts as a proto-oncogene, and its expression and activation is associated with transformation and tumorigenesis. Several pseudogenes of this gene are found on other chromosomes. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2015]
A study in human forensic autopsy cases using RNA sequencing demonstrated that the EIF4E transcript, involved in the MAPK pathway branch of insulin signaling, was upregulated in a case of fatal insulin overdose compared to control cases [Nakao et al. DOI:10.1016/j.legalmed.2025.102772].